Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients
Phase 3
Completed
- Conditions
- Kidney Transplant Recipient
- Interventions
- Biological: Janssen Ad26.CoV2.S VaccineOther: Reduction in Immunosuppression MedicationOther: Maintenance in Immunosuppression Medication
- First Posted Date
- 2022-02-02
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Mark Stegall
- Target Recruit Count
- 468
- Registration Number
- NCT05220397
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Impact of Proteasome Inhibition on Anti-Donor HLA Antibody Production After Kidney Transplantation
- First Posted Date
- 2011-05-06
- Last Posted Date
- 2015-10-28
- Lead Sponsor
- Mark Stegall
- Target Recruit Count
- 4
- Registration Number
- NCT01349595
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Transplant
- First Posted Date
- 2008-05-02
- Last Posted Date
- 2018-06-26
- Lead Sponsor
- Mark Stegall
- Target Recruit Count
- 31
- Registration Number
- NCT00670774
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath